The authors concluded that CNN treatment reduced gut inflammation in mice with induced colitis, possibly through synergistic effects of the restoration of goblet cells, increased abundance of butyrate-producing bacteria, and promotion of IgA coating of gut microbiota [141]. This evidence concerns the gene CD79A and colitis.